Reliability and validity of the Turkish version of the EORTC QLQ-C15-PAL for patients with advanced cancer

Basit Öğe Kaydı
dc.authorid0000-0002-9584-6134
dc.contributor.authorOzcelik, Hanife
dc.contributor.authorGuzel, Yasemin
dc.contributor.authorSonmez, Esra
dc.contributor.authorAksoy, Fatma
dc.contributor.authorUslu, Ruchan
dc.date.accessioned2019-08-01T13:38:39Z
dc.date.available2019-08-01T13:38:39Z
dc.date.issued2016
dc.departmentNiğde ÖHÜ
dc.description.abstractObjective: Assessing quality of life, which is the main focus of palliative care, is highly important. The number of available, specific, simple, and valid assessment instruments for patients with advanced cancer in Turkey is limited. The aim of our study was to perform a psychometric evaluation of the Turkish version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-PAL (EORTC QLQ-C15-PAL). Method: The study was conducted in Izmir with patients who had received treatment in the palliative care unit of a university hospital between November of 2011 and December of 2013. Sociodemographic and disease characteristics forms, the Karnofsky Performance Status (KPS) Scale, and the EORTC QLQ-C15-PAL Scale were employed in order to gather data. Results: A total of 150 patients completed the study: 55.3% of participants were female, 80.7% were married, and the average age was 52.76 +/- 14.55. The value of Cronbach's a in the analyses ranged from 0.93 to 0.98. Most questionnaire areas had low to moderate correlations with the others. The moderate correlations were between fatigue and physical function (-0.41) and between insomnia and emotional function (-0.53). Conversely, weak correlations were found between nausea/vomiting and appetite loss (0.31) and between insomnia and pain (0.22). KPS scores decreased, patient physical and emotional function were diminished, global QoL declined, and patients' symptoms became more frank. Significance of results: We concluded that the EORTC QLQ-C15-PAL is a valid and reliable tool to determine the quality of life of advanced cancer patients who are undergoing palliative treatment in Turkey.
dc.identifier.doi10.1017/S1478951516000195
dc.identifier.endpage634
dc.identifier.issn1478-9515
dc.identifier.issn1478-9523
dc.identifier.issue6
dc.identifier.pmid27068607
dc.identifier.scopus2-s2.0-84963579095
dc.identifier.scopusqualityQ1
dc.identifier.startpage628
dc.identifier.urihttps://dx.doi.org/10.1017/S1478951516000195
dc.identifier.urihttps://hdl.handle.net/11480/3541
dc.identifier.volume14
dc.identifier.wosWOS:000393181400005
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthor[0-Belirlenecek]
dc.language.isoen
dc.publisherCAMBRIDGE UNIV PRESS
dc.relation.ispartofPALLIATIVE & SUPPORTIVE CARE
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTurkish version of the EORTC QLQ-C15-PAL
dc.subjectPsychometric evaluation
dc.subjectAdvanced cancer
dc.titleReliability and validity of the Turkish version of the EORTC QLQ-C15-PAL for patients with advanced cancer
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu